Argentina and Mexico to produce AstraZeneca Covid-19 vaccine


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Argentina and Mexico to produce AstraZeneca Covid-19 vaccine
Argentina and Mexico will produce the AstraZeneca COVID-19 vaccine for most of Latin America

Argentina and Mexico will produce the AstraZeneca COVID-19 vaccine for most of Latin America, Argentine President Alberto Fernandez said on Wednesday after a meeting with company executives involved in the project.

Argentina's President Alberto Fernandez gestures during the announcement that Argentina and Mexico will produce and distribute an experimental coronavirus vaccine, at the Olivos Presidential residence, in Buenos Aires, Argentina August 12, 2020.

An agreement signed between British pharmaceutical company AstraZeneca and the biotechnology company mAbxience of the INSUD Group includes transfer of technology to initially produce 150 million doses of the vaccine to supply all of Latin America with the exception of Brazil, the Argentine government said.

“Latin American production will be handled in Argentina and Mexico and that will allow timely and efficient access for all countries in the region,” Fernandez said.

Mexican Foreign Minister Marcelo Ebrard said later on Twitter that the deal had been pushed by Fernandez and Mexican President Andres Manuel Lopez Obrador. He said output of the vaccine could extend to 250 million doses.

AstraZeneca, Britain’s second-largest drugmaker, has long operations in Argentina. The company signed a deal with the foundation of Mexican billionaire Carlos Slim for the production of the vaccine, which is expected to be delivered in the first half of 2021, pending Phase III studies and regulatory approvals.

Mexico would provide more details on Thursday, said Ebrard, who thanked the Slim Foundation for financing production.

Arturo Elias, Slim’s spokesman, said a “very significant” sum was being invested in the scheme, without giving a figure.

“There’s a major economic commitment regardless of whether the vaccine works,” he told Reuters, noting that the foundation would start work immediately.

Fernandez said the deal “gives Argentina the peace of mind of being able to have the vaccine when required and at a reasonable price.”

Argentina, which has passed 5,000 coronavirus fatalities, posted a record daily number of COVID-19 infections on Wednesday with 7,663 new cases. Mexico has registered nearly 55,000 deaths and almost half a million cases.

Worldwide coronavirus cases have surpassed 20.4 million, according to the Johns Hopkins University. More than 12.7 million have recovered, and more than 745,000 have died. Back at home, India's coronavirus case tally has spiked by 66,999 cases in the last 24 hours. As per the latest data issued by the Ministry of Health and Family Welfare (MoHFW), India's COVID-19 case tally has surged to 23,96,638 out of which, 16,95,982 people have recovered while 6,53,622 are still suffering from the virus. COVID-19 death toll in India has gone past 47,000 with a single day jump of 942.ack at home, 

Story Courtesy: www.reuters.com 

Tags : #ArgentinaCovidNewsAug13 #AlbertoFernandez #MexicoCovidNewsAug13 #JohnHopkins #AstraZenecaNesAug13 #AstraZeneca #LatestPharmaNewsAug13 #LatestPharmaUpdateAug13 #mAbxience #InsudGroup

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026